ArticleAging2022

Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties.

James A McCubrey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.